The Journal of Clinical Investigation is a premier venue for discoveries in basic and clinical biomedical science that will advance the practice of medicine.

  • Legacy. The JCI was founded in 1924 and is published by the ASCI, a nonprofit honor organization of physician-scientists established in 1908.
  • Impact Factor: 14.808 (2020). One of the top journals in the “Medicine, Research & Experimental” Web of Science category.
  • Broad readership and scope. Readers across a wide range of medical disciplines and sectors; basic and phase I/II clinical research articles in all biomedical specialties, including Autoimmunity, Gastroenterology, Immunology, Metabolism, Nephrology, Neuroscience, Oncology, Pulmonology, Vascular Biology, and many others.
  • Free access. All research is freely available to the public. The JCI deposits published research articles in PubMed Central, which satisfies the NIH Public Access Policy and other similar funding agency requirements.
  • Funding agency open access compliance. Authors with funding from agencies requiring open access may request a CC BY 4.0 license in order to be compliant with funding mandates, including those under Plan S. Beginning with the January 4, 2022, issue of the JCI, all content will automatically carry the CC BY 4.0 license.
  • Editorial Board. The Editorial Board includes academic editors with a broad range of expertise who are active researchers in their fields.
  • Preprint server and institutional repository posting. Authors are permitted to post manuscripts on bioRxiv and medRxiv, and to post the final published version of the manuscript in institutional repositories. 

Submit your work

  • The Editorial Board considers research submissions in the following categories: Research, Clinical Medicine, Concise Communication, and Letter to the Editor. Note: Beginning January 1, 2022, the Editorial Board will no longer consider new Concise Communication submissions. At that time, new submissions must be formatted for the Research or Clinical Medicine category as appropriate.
  • Visit the Author Information Center for complete details about manuscript submission and editorial policies.
  • Start your submission by accessing your JCI author account. If you don’t have an account yet, sign up here.
  • For any communication with the Journal, reference the assigned tracking number noted in the acknowledgment of your submission. If you do not have this information, reference the manuscript title and corresponding author’s name. Email staff@the-jci.org or call 734-222-6050.
  • To avoid confusion regarding correspondence, inquiries, and decisions, the JCI will typically communicate only with corresponding authors of submissions.

See also

 

Revision history

Updated July 21, 2021

[Top of page]

  • Reorganized information; added Letter to the Editor category; and updated Impact Factor for 2020.
Advertisement